Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 27 Jul 2026 for Edwards Lifesciences Corp. Read the official filing
Filing timeline
BuySaleBernard J. Zovighian
Insider track record
Disclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Bernard J. Zovighian: trading record in brief
Bernard J. Zovighian is a declared insider of Edwards Lifesciences Corp (chief executive), with filings sourced from SEC (Form 4). The record holds 28 filings, for trades running from 3 May 2022 to 27 July 2026.
On the market, this insider has only sold: 7 sales, €4.2M in total. Other entries cover 12 share grants and 5 option exercises. In 2026 alone, the filings show no purchases and 1 sale.
On 27 July 2026 came the latest disclosure, a transaction in Edwards Lifesciences Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Bernard J. Zovighian
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations28 total
319.65 shares0Common StockSEC:0001225208-26-006743:0
319.65 shares0Common StockSEC:0001225208-26-006743:1
2,920.551 shares@ US$83.9342Common StockSEC:0001225208-26-006743:2
47,207 shares0Common StockSEC:0001225208-26-005172:0
515 shares@ US$83.980.0001% mcap1.9% of flowCommon StockSEC:0001225208-26-004968:0
25,350 shares@ US$59.256715.7% of flowCommon StockSEC:0001225208-26-001893:0
25,350 shares@ US$59.256719.0% of flowCommon StockSEC:0001225208-25-009840:0
16,099 shares@ US$77.213819.8% of flowCommon StockSEC:0001225208-25-005684:0
5,815.551 shares0Common StockSEC:0001225208-25-005233:0
2,860 shares@ US$73.684.2% of flowCommon StockSEC:0001225208-25-005052:0
4,253 shares@ US$74.926.3% of flowCommon StockSEC:0001225208-25-004941:0
527 shares@ US$75.650.8% of flowCommon StockSEC:0001225208-25-004799:0
7,463 shares@ US$45.27677.0% of flowCommon StockSEC:0001225208-25-003195:0
8,617 shares@ US$87.6815.6% of flowCommon StockSEC:0001225208-24-006448:0
2,854 shares@ US$86.725.1% of flowCommon StockSEC:0001225208-24-005979:0
33,500 shares0Common StockSEC:0001225208-24-005886:0
527 shares@ US$85.060.9% of flowCommon StockSEC:0001225208-24-005743:0
2,558.621 shares@ US$83.53894.4% of flowCommon StockSEC:0001225208-23-007850:0
22,525 shares0Common StockSEC:0001225208-23-005916:0
5,003 shares0Common StockSEC:0001225208-23-005622:0
359 shares@ US$87.810.6% of flowCommon StockSEC:0001225208-23-005437:0
4,811 shares@ US$103.6610.9% of flowCommon StockSEC:0001225208-22-009330:0
4,809 shares@ US$87.750.0008% mcap20.5% of flowCommon StockSEC:0001225208-22-008104:0
9,000 shares@ US$100.83210.0017% mcap43.0% of flowCommon StockSEC:0001225208-22-007468:0
4,809 shares@ US$95.520.0009% mcap21.7% of flowCommon StockSEC:0001225208-22-007372:0
25 of 28 declarations
